Olliaro, P., Kuesel, A., Halleux, C., Sullivan, M., & Reeder, J. (2018). Creative use of the priority review voucher by public and not-for-profit actors delivers the first new FDA-approved treatment for river blindness in 20 years. Public Library of Science.
Cita Chicago (17th ed.)Olliaro, P., A. Kuesel, C. Halleux, M. Sullivan, i J. Reeder. Creative Use of the Priority Review Voucher by Public and Not-for-profit Actors Delivers the First New FDA-approved Treatment for River Blindness in 20 Years. Public Library of Science, 2018.
Cita MLA (9th ed.)Olliaro, P., et al. Creative Use of the Priority Review Voucher by Public and Not-for-profit Actors Delivers the First New FDA-approved Treatment for River Blindness in 20 Years. Public Library of Science, 2018.